Is Semaglutide FDA-Approved for Weight Loss? Yes - But Only One Version (And Most Are Misusing It) - Mustaf Medical
You've been waiting 12 weeks on semaglutide. Maybe even 16. You're injecting weekly, cutting calories, and still - the scale won't budge. You're not alone. Yes, semaglutide is FDA-approved for weight loss - but only the 2.4 mg dose of Wegovy, and only when paired with sustained calorie deficits. Ozempic? Not approved. Mounjaro? Not even close. And if you're using off-label versions at suboptimal doses, you're likely in the 40–60% of users who see minimal fat loss by week 20.
This isn't about motivation. It's about dosage precision, metabolic reality, and regulatory clarity. Expecting weight loss without hitting at least a 300–500 kcal/day deficit means expecting physics to bend. Semaglutide isn't a metabolic override. It's an appetite modulator. And in 2026, the most common reason it "doesn't work" is wrong dosage, not patient failure.
Why "I'm Not Losing Weight on Semaglutide" Is Mostly a Dosage Problem
Semaglutide's efficacy is dose-dependent - not linear, but threshold-dependent. Studies show sub-1.7 mg doses achieve ≤5% total body weight loss in only 30–40% of users by 68 weeks (STEP-1 trial). But at 2.4 mg (Wegovy), 60–68% hit ≥10% loss by week 68.
Most off-label use - particularly Ozempic repurposed for weight loss - stops at 1.0 mg or 2.0 mg. That's not an oversight. It's a systemic dosage gap.
Here's the breakdown:
- 0.25–0.5 mg: Appetite suppression begins but rarely exceeds 1–2% body weight loss
- 1.0 mg: Average loss: 3.5–5.2% over 6 months - mostly early water/glycogen
- 2.0 mg: ~6–7% loss in 68 weeks (off-label, no long-term data)
- 2.4 mg (FDA-approved for obesity): Median 14.9% loss at 68 weeks with diet/exercise
If you're on 1.0 mg and expecting Wegovy-level results, you're chasing a pharmacokinetic illusion. Semaglutide's half-life is ~7 days. At lower doses, Cmax (peak concentration) never reaches the threshold needed to sustain PYY and GLP-1 receptor saturation in the hypothalamus - the key to reducing hedonic eating.
And no, "just eating less" doesn't compensate. Appetite dysregulation in obesity involves leptin resistance, elevated ghrelin tone, and reward-pathway hijacking - none of which are fully corrected at sub-therapeutic doses.
Fat Loss Mechanism: Why Calories Still Rule (Even on Semaglutide)
No drug overrides thermodynamics.
Fat loss requires a calorie deficit. Full stop.
Semaglutide reduces ad libitum intake by 20–28% on average at 2.4 mg (NEJM, 2021), but that still depends on baseline intake. If you consume 3,000 kcal/day and reduce to 2,400, that's only a 600 kcal deficit - enough for ~1.2 lbs of fat loss per week, if metabolic adaptation doesn't occur.
But here's what most miss: semaglutide blunts hunger, but doesn't eliminate energy homeostasis. Your body fights back via:
- ↓ Thermic effect of food (TEF) by up to 15%
- ↓ Non-exercise activity thermogenesis (NEAT) - fidgeting drops 200–300 kcal/day
- ↑ Cortisol and adaptive leptin suppression - increasing hunger rebound risk post-treatment
So even with 2.4 mg, you must still manually calibrate intake below TDEE (total daily energy expenditure). BMR drops ~15–20% during sustained loss. At 3,000 kcal starting TDEE, you could be at 2,400 kcal maintenance by week 30 - unless you adjust.
That's why Wegovy's approval includes "chronic weight management" with lifestyle intervention, not standalone use. No GLP-1 agonist is a metabolic bypass.
Why Semaglutide "Doesn't Work" - The Expectation Gap in 2026
Most users expect 1–2 lbs per week, every week. Real-world fat loss is non-linear and phase-dependent:
- Weeks 1–8: Rapid drop - 50–70% water, glycogen, undigested mass
- Weeks 9–24: True fat loss - 0.5–1.2 lbs/week, assuming deficit
- Week 25+: Plateau risk - adaptive thermogenesis cuts loss by 30–50%
In STEP trials, median weight loss plateaued between weeks 48–60 - even at 2.4 mg - unless dietary adherence tightened.
And here's the dosage-specific failure pattern:
- Underdosed (≤1.0 mg): No significant fat loss after week 12 - appetite suppression fades
- Slow titration (e.g., 4+ months to 2.4 mg): Lost time - 6–8 kg of avoidable delay
- Dose holds due to GI side effects: Incomplete receptor engagement
Most "failures" aren't drug failure. They're dosage-pathway divergence.
Also: liraglutide (Saxenda), another GLP-1, requires 3.0 mg daily for weight loss - but only achieves ~8% loss over 56 weeks. Why? Lower receptor affinity and shorter half-life. Not all GLP-1s are equivalent.
Quick Verdict: Semaglutide for Weight Loss - Only If Dosed Right
Yes, semaglutide is FDA-approved for weight loss - Wegovy (2.4 mg) in June 2021. Ozempic? Approved for type 2 diabetes. Mounjaro? Tirzepatide - dual GIP/GLP-1 - not semaglutide.
If you're using less than 2.4 mg, you're not on the weight-loss dose. And if you're not in a calorie deficit of at least 300–700 kcal/day, the drug is working against physics.
Wegovy isn't magic. It's a tool for adherence - not a standalone solution. For most, it reduces the effort to maintain a deficit. But without tracking intake and adjusting for metabolic slowdown, even 2.4 mg fails.
Use it right: full dose, slow titration, sustained deficit, and professional supervision. Otherwise, you're just paying $1,300/month for modest appetite tweaks.
People Also Ask
Why am I not losing weight on semaglutide?
Most likely: wrong dose (<2.4 mg), insufficient calorie deficit, or metabolic adaptation. GI side effects may also limit titration, reducing efficacy.
How long does semaglutide take to work for weight loss?
Meaningful fat loss begins at week 9–12. Early drops are water/glycogen. At 2.4 mg, expect 0.5–1 lb of fat loss per week after month 3.
Is semaglutide better than a calorie deficit?
No. Semaglutide works by helping you maintain a calorie deficit. Without a deficit, no fat loss occurs, regardless of dose.
Does Ozempic work for weight loss like Wegovy?
Not reliably. Ozempic maxes at 2.0 mg (vs. Wegovy's 2.4 mg). Studies show significantly lower weight loss at equivalent doses.
Why is my weight loss stalled on semaglutide?
Common causes: metabolic adaptation (↓BMR), NEAT reduction, water retention, or unintentional calorie creep. Reassess intake and activity.
Can you lose weight on semaglutide without dieting?
Minimal fat loss. One trial showed ~3% body weight loss without diet changes at 2.4 mg - but 80% regained it within 12 months post-treatment.
What's the difference between Wegovy and generic semaglutide for weight loss?
Wegovy is FDA-approved, dosed to 2.4 mg, and studied for obesity. "Generic" versions (e.g., compounded) vary in purity, concentration, and sterility - risk not worth the cost cut.